These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27089193)

  • 21. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
    Ito K
    Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging after local tumor therapies: kidney and liver.
    Kielar AZ; Hibbert RM; Maturen KE
    Semin Roentgenol; 2013 Jul; 48(3):273-84. PubMed ID: 23796378
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatocellular carcinoma and precancerous lesions: advances in imaging.
    Choi BI
    Abdom Imaging; 2002; 27(2):115-6. PubMed ID: 11847570
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatocellular carcinoma: diagnostic criteria by imaging techniques.
    Ronot M; Vilgrain V
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):795-812. PubMed ID: 25260309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
    Chou CT; Chen YL; Su WW; Wu HK; Chen RC
    J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Education and imaging. Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging.
    Eso Y; Marusawa H; Osaki Y
    J Gastroenterol Hepatol; 2012 Feb; 27(2):416. PubMed ID: 22260287
    [No Abstract]   [Full Text] [Related]  

  • 28. Liver-specific magnetic resonance contrast medium in the evaluation of chronic liver disease.
    Reis MA; Baroni RH
    Einstein (Sao Paulo); 2015; 13(2):326-9. PubMed ID: 26154554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small scirrhous hepatocellular carcinoma with central scar: MR imaging findings.
    Goshima S; Kanematsu M; Yamada T; Kondo H; Matsuo M; Osada S; Nakashima O; Moriyama N; Hoshi H
    J Magn Reson Imaging; 2002 Dec; 16(6):741-5. PubMed ID: 12451588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical magnetic resonance imaging findings in hepatocellular carcinoma.
    Roumanis PS; Bhargava P; Kimia Aubin G; Choi JI; Demirjian AN; Thayer DA; Lall C
    Curr Probl Diagn Radiol; 2015; 44(3):237-45. PubMed ID: 25823550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
    Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
    J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MR contrast agent: resovist (SH U 555A)].
    Nakajima H; Ichikawa T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.
    Motosugi U; Bannas P; Sano K; Reeder SB
    J Magn Reson Imaging; 2015 Feb; 41(2):251-65. PubMed ID: 25104398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guest editor's introduction: hepatocellular nodules in liver cirrhosis: imaging update 2011.
    Choi BI
    Abdom Imaging; 2011 Jun; 36(3):230-1. PubMed ID: 21267564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of hepatocellular carcinoma using contrast media.
    Kim MJ; Choi JY; Chung YE; Choi SY
    Oncology; 2008; 75 Suppl 1():72-82. PubMed ID: 19092275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications of clinical uses of contrast agents for MR imaging of liver].
    Chen F; Ni YC
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):299-300. PubMed ID: 15854502
    [No Abstract]   [Full Text] [Related]  

  • 37. [Progresses in detecting small hepatocellular carcinoma with digital subtraction angiography, CT and MRI].
    Zeng Y; Zhao JN
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):572-3. PubMed ID: 14552734
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of hepatocellular carcinoma and early diagnosis.
    Limaye AR; Cabrera R
    Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
    Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
    Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.